Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis

BACKGROUND AND AIM: Ursodeoxycholic acid (UDCA) is the standard treatment for primary biliary cirrhosis (PBC), but not all cases respond well. Evidence has shown that combination therapy of UDCA with bezafibrate significantly improved liver function. A meta-analysis was performed to assess the effic...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Drug Des Devel Ther
Glavni autori: Yin, Qin, Li, Jingjing, Xia, Yujing, Zhang, Rong, Wang, Jianrong, Lu, Wenxia, Zhou, Yuqing, Zheng, Yuanyuan, Abudumijiti, Huerxidan, Chen, Rongxia, Chen, Kan, Li, Sainan, Liu, Tong, Wang, Fan, Lu, Jie, Zhou, Yingqun, Guo, Chuanyong
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599574/
https://ncbi.nlm.nih.gov/pubmed/26491252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S92041
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items